These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Information and consent forms for sublingual immunotherapy. Demoly P; André C Clin Allergy Immunol; 2008; 21():527-34. PubMed ID: 18828527 [No Abstract] [Full Text] [Related]
4. [Other forms of immunomodulation in allergic patients]. Cortegano I; Del Pozo V; Rojo M; Cárdaba B; Aceituno E; Gallardo S; Mínguez A; Arrieta I; Palomino P; Lahoz C Allergol Immunopathol (Madr); 2000; 28(3):102-7. PubMed ID: 10867378 [No Abstract] [Full Text] [Related]
5. [Recombinant allergens for specific immunotherapy]. Kowalski ML; Balwierz A Pol Merkur Lekarski; 2003 Jun; 14(84):685-7. PubMed ID: 14524305 [TBL] [Abstract][Full Text] [Related]
6. Innovation in immunotherapy. Thomas WR Clin Exp Allergy; 2009 Apr; 39(4):450-4. PubMed ID: 19317800 [No Abstract] [Full Text] [Related]
7. [DNA vaccines to allergic diseases and upcoming clinical application]. Sano K Nihon Rinsho; 2005 May; 63 Suppl 5():73-9. PubMed ID: 15954328 [No Abstract] [Full Text] [Related]
8. Drugs for allergic disorders. Treat Guidel Med Lett; 2007 Aug; 5(60):71-80. PubMed ID: 17703144 [No Abstract] [Full Text] [Related]
9. [Cytokines and anti-cytokines in allergic diseases]. Fal AM Pol Merkur Lekarski; 2003 Jun; 14(84):613-6. PubMed ID: 14524284 [TBL] [Abstract][Full Text] [Related]
10. Experimental forms of allergen immunotherapy with modified allergens and adjuvants. Mohapatra SS; San-Juan-Vergara H; Wopfner N; Ferreira F Clin Allergy Immunol; 2008; 21():393-413. PubMed ID: 18828519 [No Abstract] [Full Text] [Related]
14. Targeting the MHC II presentation pathway in allergy vaccine development. Rhyner C; Kündig T; Akdis CA; Crameri R Biochem Soc Trans; 2007 Aug; 35(Pt 4):833-4. PubMed ID: 17635159 [TBL] [Abstract][Full Text] [Related]
15. Drugs for allergic disorders. Treat Guidel Med Lett; 2010 Feb; 8(90):9-18; quiz 2 p following 18. PubMed ID: 20094023 [No Abstract] [Full Text] [Related]
16. Immunotherapy: the next 100 years. Finegold I; Oppenheimer J Ann Allergy Asthma Immunol; 2010 Nov; 105(5):394-8. PubMed ID: 21055667 [No Abstract] [Full Text] [Related]
17. [Diagnosis and treatment of allergic diseases by means of allergens and vaccines of domestic production]. Kruczalowa M; Weiss A Pol Tyg Lek; 1968 Mar; 23(11):405-6. PubMed ID: 5668776 [No Abstract] [Full Text] [Related]
18. Preparing and mixing allergen vaccines for subcutaneous immunotherapy. Nelson HS Clin Allergy Immunol; 2008; 21():303-20. PubMed ID: 18828513 [No Abstract] [Full Text] [Related]
19. T regulatory cells in allergen-specific immunotherapy. Verhagen J; Taylor A; Blaser K; Akdis M; Akdis CA Int Rev Immunol; 2005; 24(5-6):533-48. PubMed ID: 16318994 [TBL] [Abstract][Full Text] [Related]
20. Genetic allergen modification in the development of novel approaches to specific immunotherapy. Mutschlechner S; Deifl S; Bohle B Clin Exp Allergy; 2009 Nov; 39(11):1635-42. PubMed ID: 19624521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]